Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0196
+0.0008 (4.26%)
Sep 29, 2025, 10:28 AM CET
-95.63%
Market Cap 947.10K
Revenue (ttm) 3.00K
Net Income (ttm) 119.00K
Shares Out 50.38M
EPS (ttm) 0.09
PE Ratio 0.20
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 209,816
Average Volume 413,939
Open 0.0192
Previous Close 0.0188
Day's Range 0.0188 - 0.0198
52-Week Range 0.0168 - 0.4500
Beta 0.47
RSI 34.46
Earnings Date Sep 5, 2025

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.